Involvement of spinal μ1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception

European Journal of Pharmacology

Volumn 540, Issue 1-3, 2006, Pages 67-72

  Mizoguchi, Hirokazu ^a   Nakayama, Daisuke ^a   Watanabe, Hiroyuki ^a   Ito, Kanenori ^a   Sakurada, Wataru ^a   Sawai, Toshiki ^a   Fujimura, Tsutomu ^b   Sato, Takumi ^c   Sakurada, Tsukasa ^d   Sakurada, Shinobu ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^d DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

Opioid receptor; (Mouse); Antinociception; Dermorphin; Spinal cord; Tyr d Arg Phe sarcosine

Indexed keywords

DERMORPHIN DERIVATIVE; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU 1 OPIATE RECEPTOR; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; TETRAPEPTIDE; TYROSINE DEXTRO ARGINYL PHENYLALANYL SARCOSINE; TYROSINE DEXTRO PROLYL TRYPTOPHYL GLYCYL AMIDE; UNCLASSIFIED DRUG; ANALGESIC AGENT; DRUG DERIVATIVE; ENDOMORPHIN 1; ISOPROTEIN; MELANOSTATIN; NARCOTIC ANALGESIC AGENT; OLIGOPEPTIDE; TYROSYL ARGINYL PHENYLALANYL SARCOSINE; TYROSYL PROLYL TRYPTOPHYL GLYCINAMIDE; TYROSYL-ARGINYL-PHENYLALANYL-SARCOSINE; TYROSYL-PROLYL-TRYPTOPHYL-GLYCINAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TAIL FLICK TEST; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; HEAT; HYPERALGESIA; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PAIN ASSESSMENT; SPINAL CORD;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HEAT; HYPERALGESIA; INJECTIONS, SPINAL; MALE; MICE; MSH RELEASE-INHIBITING HORMONE; OLIGOPEPTIDES; PAIN MEASUREMENT; PROTEIN ISOFORMS; RECEPTORS, OPIOID, MU; SPINAL CORD;

EID: 33744980853     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.04.029     Document Type: Article

References (30)

1. 1) in the trigeminal dorsal horn. J. Neurosci. 20 (2000) 4345-4354
2. Aicher S.A., Sharma S., Cheng P.Y., Liu-Chen L.Y., and Pickel V.M. Dual ultrastructural localization of μ-opiate receptors and substance P in the dorsal horn. Synapse 36 (2000) 12-20
3. Broccardo M., Erspamer V., Falconieri Erspamer G., Improta G., Linari G., Melchiorri P., and Montecucchi P.C. Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin. Br. J. Pharmacol. 73 (1981) 625-631
4. de Castiglione R., and Rossi A.C. Structure-activity relationships of dermorphin synthetic analogues. Peptides 6 (1985) 117-125
5. Elliott J., Smart D., Lambert D.G., and Traynor J.R. Characterization of μ-opioid receptors on SH-SY5Y cells using naloxonazine and β-funaltrexamine. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 268 (1994) 447-450
6. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67 (1980) 313-316
7. Krumins S.A. Characterization of dermorphin binding to membranes of rat brain and heart. Neuropeptides 9 (1987) 93-102
8. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., and Watson S.J. μ-, δ-, and κ-Opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350 (1994) 412-438
9. Mansour A., Fox C.A., Thompson R.C., Akil H., and Watson S.J. μ-Opioid receptor mRNA expression in the rat CNS: comparison to μ-receptor binding. Brain Res. 643 (1994) 245-265
10. 1-opioid receptors in dermorphin tetrapeptide analogues-induced antinociception. Eur. J. Pharmacol. 486 (2004) 19-24
11. Montecucchi P.C., de Castiglione R., Piani S., Gozzini L., and Erspamer V. Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phyllomedusa sauvagei. Int. J. Pept. Protein Res. 17 (1981) 275-283
12. Moskowitz A.S., and Goodman R.R. Autoradiographic distribution of mu1 and mu2 opioid binding in the mouse central nervous system. Brain Res. 360 (1985) 117-129
13. Otsuka M., and Konishi S. Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat. Nature 264 (1976) 83-84
14. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16 (1993) 1-18
15. Paul D., Bodner R.J., Gistrak M.A., and Pasternak G.W. Different μ receptor subtypes mediated spinal and supraspinal analgesia in mice. Eur. J. Pharmacol. 168 (1989) 307-314
16. Sakurada S., Zadina J.E., Kastin A.J., Katsuyama S., Fujimura T., Murayama K., Yuki M., Ueda H., and Sakurada T. Differential involvement of μ-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. Eur. J. Pharmacol. 372 (1999) 25-30
17. Sakurada S., Hayashi T., Yuhki M., Fujimura T., Murayama K., Yonezawa A., Sakurada C., Takeshita M., Zadina J.E., Kastin A.J., and Sakurada T. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res. 881 (2000) 1-8
18. Sakurada S., Takeda S., Sato T., Hayashi T., Yuki M., Kutsuwa M., Tan-No K., Sakurada C., Kisara K., and Sakurada T. Selective antagonism by naloxonazine of antinociception by Tyr-d-Arg-Phe-β-Ala, a novel dermorphin analogue with high affinity at μ-opioid receptors. Eur. J. Pharmacol. 395 (2000) 107-112
19. Sakurada S., Hayashi T., Yuhki M., Orito T., Zadina J.E., Kastin A.J., Fujimura T., Murayama K., Sakurada C., Sakurada T., Narita M., Suzuki T., Tan-no K., and Tseng L.F. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur. J. Pharmacol. 427 (2001) 203-210
20. 2 discriminate different μ-opioid receptor mediated antinociception in mice. Br. J. Pharmacol. 137 (2002) 1143-1146
21. Salvadori S., Sarto G., and Tomatis R. Synthesis and pharmacological activity of dermorphin and its N-terminal sequences. Int. J. Protein Res. 19 (1982) 536-542
22. 2-dermorphin tetrapeptide analogs: a potent and long-lasting analgesic activity after subcutaneous administration. Biochem. Biophys. Res. Commun. 120 (1984) 214-218
23. Sato T., Sakurada S., Sakurada T., Furuta S., Nakata N., Kisara K., Sasaki Y., and Suzuki K. Comparison of the antinociceptive effect between d-Arg containing dipeptides and tetrapeptides in mice. Neuropeptides 4 (1984) 269-279
24. 2-substituted tetrapeptides. J. Pharmacol. Exp. Ther. 242 (1987) 654-659
25. 1-opioid receptors to morphine-induced antinociception. Eur. J. Pharmacol. 369 (1999) 183-187
26. Skilling S.R., Smullin D.H., Beitz A.J., and Larson A.A. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J. Neurochem. 51 (1988) 127-132
27. Smullin D.H., Skilling S.R., and Larson A.A. Interaction between substance P calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord. Pain 42 (1990) 93-101
28. Stevens C.W., and Yaksh T.L. Spinal action of dermorphin, an extremely potent opioid peptide from frog skin. Brain Res. 385 (1986) 300-304
29. 2-opioid receptor antagonist in the mouse. J. Pharmacol. Exp. Ther. 312 (2005) 1075-1081
30. Watanabe H., Nakayama D., Yuhki M., Sawai T., Sakurada W., Katsuyama S., Hayashi T., Watanabe C., Mizoguchi H., Sakurada T., and Sakurada S. Differential inhibitory effects of μ-opioids on substance P- and capsaicin-induced nociceptive behavior in mice. Peptides 27 (2006) 760-768